bone biologics
-
Biologics
Bone Biologics Preclinical Study Shows rhNELL-1 Effectively Promotes Bone Formation
January 7, 2020 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for spine fusion, trauma and osteoporosis…
Read More » -
Financial
Bone Biologics Completes $5.9 Million of Financing
July 23, 2018 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets,…
Read More » -
Financial
Bone Biologics Completes $500,000 of Financing
March 29, 2018 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets,…
Read More » -
Biologics
Bone Biologics Release: New Preclinical Data For Spine Fusion Demonstrates Osteopromotive Properties
December 20, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corp. (OTC QB: BBLG), a developer of orthobiologic products for the spinal fusion,…
Read More » -
Spine
Bone Biologics Adds Osteoporosis and Trauma Indications to its Portfolio
August 23, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corp (OTC: BBLG), a developer of orthobiologic products for domestic and international spine…
Read More » -
Financial
Bone Biologics Completes $1.4 Million Round of Financing
August 22, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTC: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets,…
Read More » -
Biologics
Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Directors
August 03, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corp. (OTCQB: BBLG) announced that Bret Hankey has joined the company’s board of…
Read More » -
Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation and the Addition of Board Member, Mark Spilker
THOUSAND OAKS, Calif., March 10 /PRNewswire/ — Bone Biologics, Inc. announced today it had received another round of investment for preferred shares…
Read More »